MENU
+Compare
ALNY
Stock ticker: NASDAQ
AS OF
Apr 3, 01:14 PM (EDT)
Price
$260.86
Change
-$5.97 (-2.24%)
Capitalization
34.53B

ALNY Alnylam Pharmaceuticals Forecast, Technical & Fundamental Analysis

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ALNY with price predictions
Apr 02, 2025

Momentum Indicator for ALNY turns positive, indicating new upward trend

ALNY saw its Momentum Indicator move above the 0 level on March 17, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ALNY just turned positive on March 17, 2025. Looking at past instances where ALNY's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

ALNY moved above its 50-day moving average on April 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ALNY crossed bullishly above the 50-day moving average on March 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ALNY advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ALNY moved out of overbought territory on March 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where ALNY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALNY broke above its upper Bollinger Band on March 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALNY entered a downward trend on March 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALNY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALNY's P/B Ratio (500.000) is very high in comparison to the industry average of (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (14.514) is also within normal values, averaging (252.036).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALNY is expected to report earnings to fall 1,644.33% to -92 cents per share on May 01

Alnylam Pharmaceuticals ALNY Stock Earnings Reports
Q1'25
Est.
$-0.93
Q4'24
Beat
by $0.64
Q3'24
Beat
by $0.43
Q2'24
Beat
by $1.61
Q1'24
Beat
by $0.98
The last earnings report on February 13 showed earnings per share of 5 cents, beating the estimate of -57 cents. With 137.07K shares outstanding, the current market capitalization sits at 34.53B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NPRTX46.45N/A
N/A
Neuberger Berman Large Cap Value Inv
RSCCX8.80N/A
N/A
Victory RS Small Cap Equity C
BEMIX8.91N/A
N/A
Brandes Emerging Markets Value I
TSEGX14.71N/A
N/A
Touchstone Sands Cptl Emerg Mkts Gr Inst
TRZIX14.18N/A
N/A
T. Rowe Price Small-Cap Index Z

ALNY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+4.33%
IONS - ALNY
50%
Loosely correlated
+5.32%
ATRA - ALNY
44%
Loosely correlated
+2.00%
SGMO - ALNY
42%
Loosely correlated
+14.58%
ARGX - ALNY
40%
Loosely correlated
+2.91%
AMLX - ALNY
40%
Loosely correlated
+13.17%
More